1710
V. G. Pawar et al. / Tetrahedron Letters 46 (2005) 1707–1710
Table 1. Deprotection of the scaffolds
R3
R6
R7
Path 1
Path 2
Product
Product
Yieldmethod (%)
Product
Yield (%)
Product
Yield (%)
Yieldmethod (%)
Bn
Bn
Bn
H
Bn
H
Fmoc
Fmoc
Boc
8a
8b
8c
8d
67a
66a
—
55a
70b
10a
10b
10c
10d
52
68
—
64
9a
9b
9c
9d
42
71
90
69
10a
10b
10c
10d
—
70a
00a
60a
73b
H
Isobutyl
Fmoc
a See method a in Scheme 5.
b See method b in Scheme 5.
Fmoc based scaffolds seem to be the more feasible ones.
A first peptide analogue has been prepared demonstrat-
ing that the APC-scaffold can be introduced into the
peptide sequence with an appropriate coupling reagent
and using a longer coupling time. The synthesis of the
other substance P analogues and biological testing is un-
der current investigation.
Acknowledgements
The authors thank the F.W.O. (Fund for Scientific Re-
search–Flanders (Belgium)) and the Johnson and John-
son Pharmaceutical Research Foundation for financial
support. W.M.D.B. (Postdoctoral Fellow of the
F.W.O.) and V.M. (Research Assistant of the F.W.O.)
thank the F.W.O. for the fellowship received.
Scheme 6. Synthesis of SP (6–11) APCanalogue.
used in order to obtain the C-terminal carboxamide.
Successive couplings with the common N-Fmoc pro-
tected amino acids (used in standard threefold excess)
were accomplished by reaction with HOBT/DICin
DMF and were completed within 2 h. However, attach-
ment of the more hindered Gly-Leu APCscaffold 10d
(twofold excess) required activation with TBTU in
DMF and took 16 h for completion (ninhydrin test).
The N-terminal Gln residue (with a trityl protected side-
chain) was capped with acetic anhydride. Finally, the
peptide was cleaved from the resin and detritylated
References and notes
1. De Borggraeve, W. M.; Rombouts, F. J. R.; Van der
Eycken, E. V.; Toppet, S. M.; Hoornaert, G. J. Tetrahe-
dron Lett. 2001, 42, 5693–5695.
2. De Borggraeve, W. M.; Verbist, B. M. P.; Rombouts, F. J.
R.; Pawar, V. G.; Smets, W. J.; Kamoune, L.; Alen, J.;
Van der Eycken, E. V.; Compernolle, F.; Hoornaert, G. J.
Tetrahedron 2004, 60, 11597–11612.
using
TFA/water/ethylene-dithiol/triisopropylsilane
(95:2:2:1). Following purification by reverse-phase-
HPLC(C18, acetonitrile–water gradient), the peptide
was obtained with 26.5% yield and 99% purity. Due to
the incorporation of the racemic APCsystem, the pep-
tide consists of a mixture of two diastereoisomers, as
confirmed by the presence of two peaks in the chromato-
gram, which could both be characterised by LC–MS
(electrospray ionisation, MH+ ion observed at m/z
809). The amino acid sequence of the peptide was con-
firmed by further MS/MS analysis of the MH+ ion,
which resulted in specific cleavages of the amide linkages
to form mainly fragment ions of the type H3N+-chain-
MetNH2 retaining the C-terminus, for example, m/z
639 and 492.
3. Fink, B. E.; Kym, P. R.; Katzenellenbogen, J. A. J. Am.
Chem. Soc. 1998, 120, 4334–4344.
4. Fisher, J. W.; Trinkle, K. L. Tetrahedron Lett. 1994, 35,
2505–2508.
5. Jih Ru Hwu; Jain, M. L.; Shwu-Chen Tsay; Hakimelahi,
G. H. Tetrahedron Lett. 1996, 37, 2035–2038.
6. Levian-Teitelbaum, D.; Kolodny, N.; Chorev, M.; Selin-
ger, Z.; Gilon, C. Biopolymers 1989, 28, 51–64.
7. Logan, M. E.; Goswami, R.; Tomczuk, B. E.; Venepalli,
B. R. Annu. Rep. Med. Chem. 1991, 26, 43–51.
8. Payan, D. G. Annu. Rev. Med. 1989, 40, 341–352.
9. Tallon, M.; Ron, D.; Halle, D.; Amodeo, P.; Saviano, G.;
Temussi, P. A.; Selinger, Z.; Naider, F.; Chorev, M.
Biopolymers 1993, 33, 915–926.
10. Tong, Y. S.; Fobian, Y. M.; Wu, M. Y.; Boyd, N. D.;
Moeller, K. D. J. Org. Chem. 2000, 65, 2484–2493.
11. Verbist, B. M. P.; Smets, W. J.; De Borggraeve, W. M.;
Compernolle, F.; Hoornaert, G. J. Tetrahedron Lett. 2004,
45, 4371–4374.
7. Conclusion
In summary, we have elaborated the concept of synthesi-
sing sidechain adapted APCscaffolds, which are suit-
able to perform a cis-peptide bond scan of the b-turn
containing region of a peptide. The synthesis of both
Fmoc and Boc protected derivatives was tried, but the
12. Von Euler, U. S.; Gaddum, J. H. J. Physiol. (London)
1931, 72, 74–87.
13. Ward, P.; Ewan, G. B.; Jordan, C. C.; Ireland, S. J.;
Hagan, R. M.; Brown, J. R. J. Med. Chem. 1990, 33,
1848–1851.